CSI Market
Sign In | Register

Bellicum Pharmaceuticals Inc (BLCM) Annual Balance Sheets

Annual · GAAP · USD millions
Access BLCM quarterly Balance Sheets →
Balance sheet data covering Bellicum Pharmaceuticals Inc–Dec 31 2018 offers a view into how Dec 31 2022's financial position has changed alongside business activity.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2022)
(Dec 31 2021) (Dec 31 2020) (Dec 31 2019) (Dec 31 2018)
Assets
Cash & cash equivalent21.84
Available-for-sale Securities, Debt Securities, Current MA0.00
Cash & Short-term Investments21.00
Accounts receivable0.00
Other Current Assets0.00
Prepaid Expense And Other Assets Current1.96
Total Current Assets23.80
Equipment/Property/Plant Net0.02
Long-term investments0.00
Other Assets, Noncurrent0.00
Restricted Cash Current0.00
Assets Held For Sale Not Part Of Disposal Group Current0.00
Operating Lease Right Of Use Asset0.00
Total Assets23.82
Liabilities
Accounts Payable, Current AC0.49
Accrued Liabilities, Current AC2.48
Derivative Liability, Current DE0.81
Long-term Debt, Current Maturities LO0.00
Other Liabilities, Current0.00
Deferred Liability and Revenue0.00
Total Current Liabilities3.77
Long-term debt0.00
Capital Lease Obligations, Noncurrent LO0.00
Total Long-term Debt0.00
Deferred credits, Noncurrent0.00
Derivative Liability Private Placement Option-
Liabilities Held For Sale Not Part Of Disposal Group Current-
Lease Liability Noncurrent-
Total Liabilities3.77
Stockholders' Equity
Treasury Stock Common Value-5.06
Common Stock Value0.09
Treasury Stock Value0.00
Additional Paid In Capital Common Stock582.76
Retained Earnings / Accumulated Deficit-575.43
Other Equity-18.39
Common Stockholder's Equity-16.02
Non-controlling interests & other18.04
Total Stockholder's Equity2.02
Liabilities & Stockholder's Equity23.82
4 historic quarters locked

Sign in to unlock the full Bellicum Pharmaceuticals Inc balance sheet history.

Sign In Create Free Account

About Bellicum Pharmaceuticals Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001628280-23-038953

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.